THERAPEUTICSMD INC (TXMD) Stock Price, Forecast & Analysis
NASDAQ:TXMD • US88338N2062
TXMD Key Statistics, Chart & Performance
The current stock price of TXMD is 2.36 USD. In the past month the price increased by 5.36%. In the past year, price increased by 129.13%.
TXMD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to TXMD. When comparing the yearly performance of all stocks, TXMD is one of the better performing stocks in the market, outperforming 95.5% of all stocks.
TXMD Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to TXMD. While TXMD seems to be doing ok healthwise, there are quite some concerns on its profitability.
TXMD Financial Highlights
Over the last trailing twelve months TXMD reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS increased by 102.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.8% | ||
| ROA | 0.78% | ||
| ROE | 1.1% | ||
| Debt/Equity | 0 |
TXMD Forecast & Estimates
TXMD Ownership
TXMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.99 | 981.56B | ||
| JNJ | JOHNSON & JOHNSON | 20.9 | 589.194B | ||
| MRK | MERCK & CO. INC. | 22.44 | 295.956B | ||
| PFE | PFIZER INC | 9.18 | 156.186B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.98 | 121.86B | ||
| ZTS | ZOETIS INC | 18.44 | 55.368B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.71 | 25.86B | ||
| VTRS | VIATRIS INC | 6.23 | 18.186B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.04 | 12.317B | ||
| AXSM | AXSOME THERAPEUTICS INC | 221.27 | 9.222B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TXMD
Company Profile
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Company Info
THERAPEUTICSMD INC
951 Yamato Road, Suite 220
Boca Raton FLORIDA 33431 US
CEO: Robert G. Finizio
Employees: 1
Phone: 15619611900
THERAPEUTICSMD INC / TXMD FAQ
What does THERAPEUTICSMD INC do?
TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
What is the stock price of THERAPEUTICSMD INC today?
The current stock price of TXMD is 2.36 USD. The price decreased by -2.48% in the last trading session.
Does TXMD stock pay dividends?
TXMD does not pay a dividend.
What is the ChartMill technical and fundamental rating of TXMD stock?
TXMD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Can you provide the number of employees for THERAPEUTICSMD INC?
THERAPEUTICSMD INC (TXMD) currently has 1 employees.
Can you provide the market cap for THERAPEUTICSMD INC?
THERAPEUTICSMD INC (TXMD) has a market capitalization of 27.31M USD. This makes TXMD a Nano Cap stock.